Sign in
Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study
Journal article   Open access  Peer reviewed

Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study

Carl H. Göbel, Axel Heinze, Sarah Karstedt, Mascha Morscheck, Lilian Tashiro, Anna Cirkel, Qutyaba Hamid, Rabih Halwani, Mohamad-Hani Temsah, Malte Ziemann, …
Pain and therapy, Vol.10(2), pp.1309-1330
01/12/2021
PMCID: 8314854
PMID: 34313952

Abstract

Cerebral venous thrombosis ChAdOx1 nCoV-19 (AZD1222) vaccine COVID-19 Headache ICHD-3 International Classification of Headache Disorders Novel coronavirus SARS-CoV-2 Original Research Side effects Vaccination
url
https://doi.org/10.1007/s40122-021-00296-3View
Published (Version of record) Open

Details